We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
-1.6%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$8.57B
AUM Growth
+$1.08B
(+14%)
Cap. Flow
+$296M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
8.97%
Holding
2,835
New
678
Increased
782
Reduced
516
Closed
536
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NIMC
NiSource Inc. Series A Corporate Units
NIMC
|
+$101M |
| 2 |
Xcel Energy
XEL
|
+$60.8M |
| 3 |
Consolidated Edison
ED
|
+$58.5M |
| 4 |
Sempra
SRE
|
+$54M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$41.7M |
| 2 |
TRTN
Triton International Limited
TRTN
|
+$31.6M |
| 3 |
Exelon
EXC
|
+$29.3M |
| 4 |
US Bancorp
USB
|
+$26.3M |
| 5 |
American Water Works
AWK
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.15% |
| 2 | Industrials | 9.9% |
| 3 | Technology | 9.04% |
| 4 | Healthcare | 7.63% |
| 5 | Utilities | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Gevo
GEVO
$360M
| $112K | ﹤0.01% |
+94,000
| New | +$139K |
|
1977
Fate Therapeutics
FATE
$286M
| $112K | ﹤0.01% |
+52,654
| New | +$174K |
|
1978
OmniAb
OABI
$287M
| $111K | ﹤0.01% |
+21,470
| New | +$115K |
|
|
EQRX
1979
CALL
DELISTED
EQRx, Inc. Common Stock
EQRX
| $111K | ﹤0.01% |
+50,000
| New | +$107K |
|
1980
Oportun Financial
OPRT
$255M
| $110K | ﹤0.01% |
15,193
-7,482
| -33% | -$49.4K |
|
|
MPT
1981
Medical Properties Trust
MPT
$2.77B
| $109K | ﹤0.01% |
19,911
-143,077
| -88% | -$1.15M |
|
1982
Stagwell
STGW
$2.07B
| $108K | ﹤0.01% |
+23,020
| New | +$136K |
|
|
LUCK
1983
Lucky Strike Entertainment
LUCK
$914M
| $108K | ﹤0.01% |
11,213
-41,200
| -79% | -$453K |
|
|
NAPA
1984
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $105K | ﹤0.01% |
10,229
-8,119
| -44% | -$100K |
|
1985
MBIA
MBI
$261M
| $104K | ﹤0.01% |
+14,436
| New | +$120K |
|
1986
ESS Tech
GWH
$22M
| $103K | ﹤0.01% |
+3,653
| New | +$88.9K |
|
1987
Relmada Therapeutics
RLMD
$557M
| $103K | ﹤0.01% |
34,334
-366
| -1% | -$1.09K |
|
1988
Advantage Solutions
ADV
$522M
| $103K | ﹤0.01% |
1,449
-126
| -8% | -$8.37K |
|
1989
Cognyte Software
CGNT
$659M
| $101K | ﹤0.01% |
21,041
-33,381
| -61% | -$169K |
|
1990
RLJ Lodging Trust
RLJ
$1.86B
| $101K | ﹤0.01% |
+10,274
| New | +$103K |
|
1991
Lexicon Pharmaceuticals
LXRX
$1.03B
| $100K | ﹤0.01% |
91,700
+18,400
| +25% | +$32.3K |
|
|
CMBM
1992
DELISTED
Cambium Networks
CMBM
| $99.7K | ﹤0.01% |
+13,600
| New | +$147K |
|
|
TPC
1993
Tutor Perini Cor
TPC
$4.41B
| $98.7K | ﹤0.01% |
+12,600
| New | +$103K |
|
|
KNTE
1994
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $98K | ﹤0.01% |
70,000
-23,345
| -25% | -$56.1K |
|
1995
Acumen Pharmaceuticals
ABOS
$155M
| $97.5K | ﹤0.01% |
+23,500
| New | +$145K |
|
1996
Aemetis
AMTX
$106M
| $96.4K | ﹤0.01% |
23,219
+7,200
| +45% | +$44K |
|
1997
X4 Pharmaceuticals
XFOR
$375M
| $96.4K | ﹤0.01% |
+2,947
| New | +$129K |
|
1998
Douglas Elliman
DOUG
$154M
| $95.5K | ﹤0.01% |
42,240
-197,760
| -82% | -$454K |
|
|
FFWM
1999
DELISTED
First Foundation Inc
FFWM
| $91.5K | ﹤0.01% |
+15,050
| New | +$99.2K |
|
2000
UNIFI
UFI
$119M
| $91.2K | ﹤0.01% |
12,846
-27,773
| -68% | -$206K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q3 2023 Portfolio in Review
As of Q3 2023, Verition Fund Management held 2,835 positions worth $8.57B, up 14% from $7.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Verition Fund Management deployed $296M of net new capital in Q3 2023, opening 678 new positions and adding to 782 existing holdings. Its largest new stake was Arm: 600,000 shares worth $32.1M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Williams Companies, an estimated $41.7M trimmed.
- Verition Fund Management's largest Q3 2023 buy was Arm: 600,000 shares worth $32.1M.
- Verition Fund Management added most to NiSource Inc. Series A Corporate Units in Q3 2023, an estimated $101M increase.
- Verition Fund Management's biggest Q3 2023 reduction was Williams Companies, cutting an estimated $41.7M.
- Verition Fund Management fully exited Triton International Limited in Q3 2023, selling an estimated $31.6M.
- Verition Fund Management's ten largest holdings make up 9% of its $8.57B portfolio in Q3 2023.
- Verition Fund Management opened 678 new positions and closed 536 in Q3 2023.
- Verition Fund Management's portfolio value rose 14% quarter-over-quarter to $8.57B.
Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.